Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H W Reesink

Showing results (31-40 of 250) with videos related to

Pageof 25
Sort By:
Vox Sanguinis|October 1, 2003
Detection of bacterial contamination of platelet concentratesR N I Pietersz, C P Engelfriet, H W Reesink
Vox Sanguinis|August 15, 1998
Donor selection: the exclusion of high risk donors?P J van den Burg, H Vrielink, H W Reesink
Lancet (London, England)|November 26, 1994
Hepatitis C virus six years onC L van der Poel, H T Cuypers, H W Reesink
Transfusion Medicine (Oxford, England)|June 26, 2001
Comparison of two platelet additive solutionsP F van der Meer, R N Pietersz, H W Reesink
Nederlands Tijdschrift Voor Geneeskunde|December 26, 1992
[Hepatitis C; a new virus for an old disease]H W Reesink, C L van der Poel, R A Chamuleau
Transfusion|April 24, 2001
Influence of temperature, filter wettability, and timing of filtration on the removal of WBCs from RBC concentratesP F van der Meer, R N Pietersz, H W Reesink
Vox Sanguinis|September 6, 2000
Leukoreduction of platelet concentrates using a 'polishing' filterP F van der Meer, R N Pietersz, H W Reesink
Lancet (London, England)|March 14, 1987
Interpretation of isolated HIV anti-p24 reactivity in Western blot analysisP N Lelie, C L van der Poel, H W Reesink
Vox Sanguinis|January 1, 1972
Evaluation of a simple method for determination of IgG titre anti-A or-B in cases of possible ABO blood group incompatibilityH W Reesink, M van der Hart, J J van Loghem
Lancet (London, England)|November 21, 1987
Should the dose of hepatitis B vaccine be reduced in newborn babies?H M Ip, V C Wong, P N Lelie, et al.
Pageof 25

Showing results (31-40 of 250) with videos related to

Sort By:
Pageof 25
Vox Sanguinis|October 1, 2003
Detection of bacterial contamination of platelet concentratesR N I Pietersz, C P Engelfriet, H W Reesink
Vox Sanguinis|August 15, 1998
Donor selection: the exclusion of high risk donors?P J van den Burg, H Vrielink, H W Reesink
Lancet (London, England)|November 26, 1994
Hepatitis C virus six years onC L van der Poel, H T Cuypers, H W Reesink
Transfusion Medicine (Oxford, England)|June 26, 2001
Comparison of two platelet additive solutionsP F van der Meer, R N Pietersz, H W Reesink
Nederlands Tijdschrift Voor Geneeskunde|December 26, 1992
[Hepatitis C; a new virus for an old disease]H W Reesink, C L van der Poel, R A Chamuleau
Transfusion|April 24, 2001
Influence of temperature, filter wettability, and timing of filtration on the removal of WBCs from RBC concentratesP F van der Meer, R N Pietersz, H W Reesink
Vox Sanguinis|September 6, 2000
Leukoreduction of platelet concentrates using a 'polishing' filterP F van der Meer, R N Pietersz, H W Reesink
Lancet (London, England)|March 14, 1987
Interpretation of isolated HIV anti-p24 reactivity in Western blot analysisP N Lelie, C L van der Poel, H W Reesink
Vox Sanguinis|January 1, 1972
Evaluation of a simple method for determination of IgG titre anti-A or-B in cases of possible ABO blood group incompatibilityH W Reesink, M van der Hart, J J van Loghem
Lancet (London, England)|November 21, 1987
Should the dose of hepatitis B vaccine be reduced in newborn babies?H M Ip, V C Wong, P N Lelie, et al.
Pageof 25